lung cancer metastatic
Showing 26 - 50 of >10,000
NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)
Not yet recruiting
- Non-Small Cell Lung Cancer Metastatic
-
Seoul, Gangnam-gu, Korea, Republic ofSamsung Medical Center
Oct 27, 2023
Cancer Medicines in Metastatic Non-small Cell Lung Cancer in
Not yet recruiting
- Non-Small Cell Lung Cancer
- lorlatinib
- +17 more
-
Oslo, NorwayPfizer Norway
Apr 17, 2023
Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- +7 more
- WM-A1-3389
- Pembrolizumab
-
Seoul, Seocho-gu, Korea, Republic of
- +1 more
May 14, 2023
Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)
Recruiting
- Nonsmall Cell Lung Cancer
- HS-10365 capsules
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 22, 2023
NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)
Not yet recruiting
- Non-small Cell Lung Cancer
- Tislelizumab IV
- +2 more
- (no location specified)
Oct 25, 2023
Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)
Recruiting
- Non-Small-Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 25, 2023
Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)
Active, not recruiting
- Metastatic Non-small Cell Lung Cancer
- Metastatic Triple-negative Breast Cancer
- ADV/HSV-tk
- +3 more
-
Houston, TexasHouston Methodist Cancer Center
Dec 28, 2022
NSCLC Metastatic Trial in Chengdu (Camrelizumab, stereotactic body radiation therapy, Chemotherapy)
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Camrelizumab
- +2 more
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital & Institute
Jul 21, 2022
Response Rate in Patients With Advanced NSCLC on ICI
Recruiting
- Non Small Cell Lung Cancer Metastatic
- Diabetes Mellitus
- Pembrolizumab
-
Assiut, EgyptAssiut university
Oct 20, 2023
Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)
Not yet recruiting
- Colorectal Cancer
- Non-Small Cell Lung Cancer
- GDC-1971
- +2 more
- (no location specified)
Jul 12, 2023
Lung Cancer Stage IV Trial in Kaunas (Bronchoscopic cryotherapy, Pembrolizumab, Platinum based chemo)
Recruiting
- Lung Cancer Stage IV
- Bronchoscopic cryotherapy
- +2 more
-
Kaunas, LithuaniaLithuanian University of Health Sciences
Aug 16, 2023
Lung Cancer Stage IV Trial in Maastricht (Radiation)
Not yet recruiting
- Lung Cancer Stage IV
- Radiation
-
Maastricht, NetherlandsMaastricht Radiation Oncology (Maastro)
Aug 29, 2023
NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- Non-small Cell Lung Cancer Stage III
- Avelumab
- +2 more
-
La Jolla, California
- +5 more
Aug 12, 2022
Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer
Not yet recruiting
- Locally Advanced Alveolar Soft Part Sarcoma
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 10, 2023
Monitoring T Cell Responses in Melanoma, Lung and Other Cancer
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +9 more
- Biospecimen Collection
- Electronic Health Record Review
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 4, 2023
NSCLC Trial (Ivonescimab Injection, Pembrolizumab Injection)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Ivonescimab Injection
- Pembrolizumab Injection
- (no location specified)
Jun 9, 2023
Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)
Not yet recruiting
- Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Utidelone Injection
- Docetaxel Injection
- (no location specified)
Dec 30, 2022
NSCLC Trial in Shanghai (BL-M02D1)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jul 10, 2023
NSCLC Trial in Guangzhou (SKB264, Pembrolizumab, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- SKB264
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University, Cancer Center
Apr 14, 2023
I3LUNG: Integrative Science, Intelligent Data Platform for
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
-
Chicago, Illinois
- +3 more
Sep 13, 2022
NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)
Not yet recruiting
- Non-Small Cell Lung Cancer
- +2 more
-
Fairfax, VirginiaNEXT Virginia
Sep 18, 2023
NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 23, 2023
NSCLC Metastatic Trial (bevacizumab plus nab-paclitaxel and platinum)
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
- bevacizumab plus nab-paclitaxel and platinum
- (no location specified)
Jun 2, 2022